‘At DU, Over 60% Likely To Opt For 4th Yr Under FYUP'
Delhi University
are expected to pursue the optional fourth year under the four-year undergraduate programme (FYUP), vice-chancellor Yogesh Singh said on Saturday, even as questions continue to be raised about the programme's implementation and long-term viability.
"DU is ready for the fourth year," Singh said at the university's executive council (EC) meeting, where several administrative and academic proposals were tabled and approved. He added that the university is fully prepared for the rollout and that solutions are being worked out for colleges facing implementation challenges.
"In colleges which have a shortage of faculty, provision will be made for engaging some guest faculty as well as regular teachers from the same college or other colleges to take additional classes," Singh said.
However, he clarified that only regular faculty will be assigned to teach fourth-year students, while guest faculty will teach only junior classes. He further said that provision would also be made for proper payment for both teachers and non-teaching staff handling overtime duties.
You Can Also Check:
Delhi AQI
|
Weather in Delhi
|
Bank Holidays in Delhi
|
Public Holidays in Delhi
The FYUP, introduced under the National Education Policy 2020, has been surrounded by scepticism since its rollout, with concerns ranging from inadequate infrastructure and staffing to a lack of clarity in curriculum design and postgraduate admission pathways.
While the VC's remarks aimed to project confidence in the university's preparedness, some council members reiterated their earlier objections, pointing to challenges in sustaining academic rigour, ensuring research quality, and addressing equity in access.
Among other decisions, EC approved infrastructure development projects worth nearly Rs 1,912.2 crore, including hostel construction, new academic buildings, and retrofitting of old structures across campuses. The council also approved the appointment of Prof Rajni Abbi as director of the South Campus, and endorsed the setup of solar power plants in collaboration with SECI. A committee was constituted to explore the possibility of instituting a sports scholarship in memory of former Union Minister and DU alumnus Arun Jaitley, which will consult with his family.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 minutes ago
- Time of India
IndusInd Bank to raise Rs 30,000 crore through equity and debt instruments
Synopsis IndusInd Bank's board has approved raising up to Rs 30,000 crore through equity and debt instruments. The RBI has allowed the Hinduja Group, the bank's promoter, to nominate two directors to the board. This decision follows a period of crisis for the bank, marked by accounting anomalies and a CEO exit.
The Hindu
7 minutes ago
- The Hindu
Natco Pharma to acquire stake in South African firm Adcock Ingram for ₹2,000 crore
Natco Pharma has made an offer to acquire nearly 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). The proposal to acquire the stake from minority shareholders in an all cash deal is a strategic investment aimed at to expanding geographic footprint in South Africa, Natco said on Wednesday. Founded in 1890, AIHL has a diverse product portfolio, from generic and branded formulations, critical-care hospital products to consumer and home-care products. It operates across four segments -prescription, consumer, OTC and hospitals. The acquisition is expected to be completed by 2025. Post-acquisition, AIHL will continue to operate as a private South African business with Bidvest holding 64.25% and Natco 35.75%, including a prior held 0.80% stake, in the company. Post-transaction, Natco will consolidate 35.75% of AIHL net profits in its financial results. AIHL clocked revenue of $536 million in the financial year June 2024 and profit after tax of $45 million. 'Adcock Ingram is a respectable pharmaceutical company with well-recognised brands and products and maintains a leading position in the South African pharmaceutical market. The proposed transaction will provide Natco Pharma with a well-established entry into the Southern African market. It will also allow us to tap into new revenue streams and expand our footprint in one of the largest and growing emerging markets, while providing a gateway to the African continent,' CEO and Vice-Chairman Rajeev Nannapaneni said. Besides the acquisition, Natco Pharma Board also approved a proposal to incorporate a wholly owned subsidiary in South Africa with an investment of up to Rs.2,100 crore by this year to enter new geographies for growth and increased profitability. It also approved a proposal to liquidate wholly owned subsidiary Time Cap Overseas (TCOL), and directly hold the investment in step down subsidiary NatcoFarma do Brasil. Natco shares closed 2.01% higher at ₹1,034.75 apiece on the BSE.
India.com
7 minutes ago
- India.com
Good news for Narayana Murthy, Infosys earns Rs 69210000000 in…, CEO Salil Parekh says…
Narayana Murthy (File) Infosys Ltd on Wednesday reported an 8.7% year-on-year increase in net profit for the June quarter, while also narrowing its full-year revenue guidance following better-than-expected earnings growth. The IT major posted a consolidated net profit of Rs 6,921 crore for the April–June quarter of FY2025-26, up from Rs 6,368 crore in the corresponding period last year, the company said in a statement. Infosys Q1 Results The IT services company narrowed its annual revenue growth forecast to 1 per cent to 3 per cent band from a prior 0-3 per cent range. Revenue from operations at Rs 42,279 crore was 7.53 per cent higher year-on-year and 3.3 per cent quarter-on-quarter, on the back of strong performance in AI and deal wins. Net profit however fell 1.5 per cent sequentially when compared with the January-March quarter. 'Our performance in Q1 demonstrates the strength of our enterprise AI capabilities, the success in client consolidation decisions, and the dedication of our over 300,000 employees. Our large deal wins of USD 3.8 billion reflect our distinct competitive positioning and deep client relationships,' Infosys CEO and MD Salil Parekh said. Infosys CEO Salil Parekh On Q1 Results Briefing media at the Q1 earnings call, Parekh noted that the start to financial year had been strong. 'The main drivers of our growth were a leadership in enterprise AI, and a continued success in clients selecting us for consolidations. We are seeing good demand for AI agents,' he said. Geographically, North America accounted for 56.5 per cent of quarterly revenue, down from 58.9 per cent in the corresponding period of the previous fiscal. Europe increased its share to 31.5 per cent, up from 28.4 per cent in the Q1 FY25. Infosys CFO Jayesh Sanghrajka said that Europe has been strong footing for the company for past many quarters. 'That's on the back of the investment that we made a few years back in Europe. We had identified Europe as a geography to invest into and all of that is working well across sectors….but still, US remains the largest geography for us,' Sanghrajka said. The Large Deal TCV (or total contract value) stood at USD 3.8 billion.
